Hudson Bay Capital Management
XERS icon

Hudson Bay Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Hudson Bay Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-203,242
Closed -$1.21M – 724
2020
Q3 		$1.21M Buy
+203,242
New +$813K 0.02% 405

Other funds holding XERS

SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return

Hudson Bay Capital Management's XERS Position: Q4 2020 in Review

Hudson Bay Capital Management sold out of Xeris Biopharma Holdings (XERS) in Q4 2020, closing a stake of 203,242 shares — an estimated $1.21M sold.

Hudson Bay Capital Management first reported a position in XERS in Q3 2020 and held it in 1 quarter. The position peaked at $1.21M in Q3 2020. 96 funds tracked by Wall St. Rank hold XERS as of Q4 2020.

  • Hudson Bay Capital Management reported no remaining Xeris Biopharma Holdings position as of Q4 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 203,242 Xeris Biopharma Holdings shares in Q4 2020, an estimated $1.21M.
  • Hudson Bay Capital Management first reported a position in Xeris Biopharma Holdings in Q3 2020 and held it in 1 quarter.
  • Hudson Bay Capital Management's Xeris Biopharma Holdings position peaked at $1.21M in Q3 2020.
  • 96 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2020.

Based on Hudson Bay Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.